KIM, KYUNG JIN,ZHAO, WEI-MENG,PARK, HANGIL,VASQUEZ, MAXIMILIANO
申请号：
PL09825523
公开号：
PL2365828T3
申请日:
2009.11.06
申请国别(地区):
PL
年份:
2015
代理人:
摘要：
The present invention is directed toward a monoclonal antibody to fibroblast growth factor receptor 2, a pharmaceutical composition comprising same, and methods of treatment comprising administering such a pharmaceutical composition to a patient.
